title: A tailored target intervention on influence factors of quality of life in Chinese patients with hypertension.
abstract: Studies suggested that hypertension was associated with impaired health-related quality of life and it is important to find a proper and feasible management of hypertension in the community. This study evaluates the effect of a tailored target intervention on influence factors of quality of life in Chinese patients with hypertension. A cross-sectional survey was carried out to investigate 644 patients with hypertension by using the Chinese version of the short form-36, and 195 patients were screened out to participate in the tailored target intervention. Multivariate linear regression analyses showed that age, gender, educational level, high intake of fried food, household income, attitude, knowledge, blood pressure, symptoms, serious events during the past year, duration of hypertension, and number of taking anti-hypertensive medicine were significantly correlated with quality of life. Grade-based management by community physicians and physical exercise had a positive effect on quality of life. After the 6-month intervention, the control rate of hypertension was increased from 32.0% to 39.4%, and the mean systolic and diastolic blood pressure values were significantly decreased to 137.2 and 85.7 mmHg vs. 140.9 and 87.6 mmHg at baseline, respectively. The intervention program resulted in overall improvement on total score of quality of life and mean scores of all the domains except social functioning in patients with hypertension. In view of the influence factors of quality of life, taking the tailored target intervention could not only improve the quality of life of hypertensive patients, but also effectively increase the control rate of hypertension.
authors.affiliation: Department of Disease Control and Prevention, Wuxi Center for Disease Prevention and Control, Jiangsu, China. wxqianyun111@sina.com
authors.forename: Yun
authors.initials: Y
authors.lastname: Qian
authors.forename: Jingping
authors.initials: J
authors.lastname: Zhang
authors.forename: Yudi
authors.initials: Y
authors.lastname: Lin
authors.forename: Meihua
authors.initials: M
authors.lastname: Dong
authors.forename: Ming
authors.initials: M
authors.lastname: Xu
authors.forename: Yanhua
authors.initials: Y
authors.lastname: Qian
authors.forename: Leilei
authors.initials: L
authors.lastname: Wu
authors.forename: Ping
authors.initials: P
authors.lastname: Shi
authors.forename: Yizhi
authors.initials: Y
authors.lastname: Xu
authors.forename: Hongbing
authors.initials: H
authors.lastname: Shen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D002681:China; D003430:Cross-Sectional Studies; D015444:Exercise; D005260:Female; D006801:Humans; D006973:Hypertension / Q000503:physiopathology* / Q000523:psychology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011788:Quality of Life
chemical_list: D000959:Antihypertensive Agents